MiR-486 has been shown to interfere with gastric cancer cell apoptosis by regulating PTEN and PIM-1 [16, 17], and elevated expression may have a more general antiapoptotic effect as it is associated with reduced expression of the tumor suppressor p53 and the apoptosis effector caspase-3 [18]. This evidence concerns the gene TP53 and gastric cancer.